• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾移植术后红细胞增多症及其药物治疗:一例使用血管紧张素转换酶抑制剂或血管紧张素受体阻滞剂的病例

[Erythrocytosis post kidney transplantation and its pharmacological treatment: angiotensin converting enzyme inhibitors or angiotensin receptor blockers in a case].

作者信息

Duclos J

机构信息

Servicio de Medicina, Hospital Naval de Viña del Mar.

出版信息

Rev Med Chil. 2000 Feb;128(2):211-2.

PMID:10962891
Abstract

A 35 years old male is presented. Eight months after receiving a renal allograft his hypertension worsened and his packed red cell volume raised to 53.7% Enalapril was started and a 500 ml phlebotomy was performed. In three occasions packed red cell volumes decreased excessively and enalapril was discontinued. Finally, the drug was replaced with losartan, normalizing blood pressure values and stabilizing packed red cell volumes. This case illustrates the different reductions in packed red cell volumes induced by enalapril and losartan. These differences could have a therapeutic relevance.

摘要

一名35岁男性患者前来就诊。接受同种异体肾移植八个月后,他的高血压病情加重,红细胞压积升至53.7%。开始使用依那普利,并进行了500毫升静脉放血治疗。有三次红细胞压积过度降低,依那普利停药。最后,该药物被氯沙坦取代,血压值恢复正常,红细胞压积稳定。该病例说明了依那普利和氯沙坦引起的红细胞压积的不同降低情况。这些差异可能具有治疗意义。

相似文献

1
[Erythrocytosis post kidney transplantation and its pharmacological treatment: angiotensin converting enzyme inhibitors or angiotensin receptor blockers in a case].肾移植术后红细胞增多症及其药物治疗:一例使用血管紧张素转换酶抑制剂或血管紧张素受体阻滞剂的病例
Rev Med Chil. 2000 Feb;128(2):211-2.
2
Effect of the angiotensin-converting enzyme inhibitor enalapril on post-transplant erythrocytosis.血管紧张素转换酶抑制剂依那普利对移植后红细胞增多症的影响。
Hiroshima J Med Sci. 1998 Sep;47(3):121-4.
3
Comparison of the effects of enalapril and losartan on posttransplantation erythrocytosis in renal transplant recipients: prospective randomized study.
Transplantation. 2001 Aug 15;72(3):542-4. doi: 10.1097/00007890-200108150-00035.
4
Effects of losartan on the treatment of posttransplant erythrocytosis.
Clin Nephrol. 1998 Jun;49(6):370-2.
5
Influence of angiotensin-converting enzyme polymorphism gene, IGF-1, and other factors in the response rate of hematocrit to enalapril treatment in patients with posttransplant erythrocytosis.血管紧张素转换酶多态性基因、胰岛素样生长因子-1及其他因素对移植后红细胞增多症患者血细胞比容对依那普利治疗反应率的影响。
Transplant Proc. 2005 Mar;37(2):1012-3. doi: 10.1016/j.transproceed.2004.11.078.
6
Preventive effect of enalapril on erythrocytosis after renal transplantation.依那普利对肾移植后红细胞增多症的预防作用。
Transplant Proc. 1996 Jun;28(3):1555-6.
7
Role of ACE inhibitors in the treatment of erythrocytosis in patients with renal allograft.
Transplant Proc. 1994 Oct;26(5):2602-3.
8
Cough induced by losartan with resolution after substitution with enalapril.氯沙坦引起的咳嗽在换用依那普利后缓解。
Clin Ther. 2008 Mar;30(3):548-51. doi: 10.1016/j.clinthera.2008.03.003.
9
Treatment of postrenal transplant erythrocytosis. Long-term efficacy and safety of angiotensin-converting enzyme inhibitors.
Nephron. 1996;74(3):517-21. doi: 10.1159/000189445.
10
Enalapril and losartan affect lipid peroxidation in renal transplant recipients with renin-angiotensin system polymorphisms.依那普利和氯沙坦对具有肾素-血管紧张素系统基因多态性的肾移植受者脂质过氧化的影响。
Clin Biochem. 2007 Feb;40(3-4):194-200. doi: 10.1016/j.clinbiochem.2006.10.023. Epub 2006 Dec 6.